Drug Delivery Systems Market Analysis

Indication (Diabetes, Cardiovascular Disease, Multiple Sclerosis, Asthma COPD)

Drug delivery systems market from the diabetes market is anticipated to expand and register the highest CAGR of 33% over the coming years. The increasing number of diabetes patients worldwide may be attributed to the segment's expansion. According to the World Health Organisation, there are 422 million diabetics worldwide. Moreover, the high utilization of insulin injections by diabetes patients is also expected to boost the growth of this segment in the projected period.

Type (Transdermal, Inhalation, Injectable)

The injectable sector is anticipated to see the most market growth over the next years. This is attributable to individuals becoming more aware of wearable injectable medicine delivery methods. Furthermore, it is anticipated that segmental expansion will be aided in the coming years by the expanding immunization campaign that is increasing syringe usage globally. Also it is anticipated that until vaccines are completed, the growing need for needles and syringes will fuel segmental expansion.

Our in-depth analysis of the global market includes the following segments: